Eventide Asset Management, Llc - Jun 30, 2025 SCHEDULE 13G/A Report for Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX)

Filing Manager
EVENTIDE ASSET MANAGEMENT, LLC
Reporting Manager
Eventide Asset Management, LLC
Security
Celldex Therapeutics, Inc. Common Stock, par value $0.001
Symbol
CLDX
Shares outstanding
67.8M shares
Disclosed Ownership
1.36M shares
Ownership
2%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 02:59 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Eventide Asset Management, LLC 2% 1.36M 1.36M 0 /s/ Peter J. Luiso Peter J. Luiso, General Counsel
Finny Kuruvilla, M.D. Ph. D. 2% 1.36M 0 1.36M /s/ Finny Kuruvilla, M.D., Ph. D. Finny Kuruvilla, M.D., Ph. D.
Robin C. John 2% 1.36M 0 1.36M /s/ Robin C. John Robin C. John